News in Orthopedics Today highlights the success of CellCoTec's INSTRUCT technology on hyaline cartilage growth
CellCoTec will attend the sixteenth ESSKA Congress form 14-17 May in The Netherlands
CellCoTec Ltd announced today it has been selected to present at the Cavendish Global Health Impact Forum in New York
European Orthopaedic Product News advertisement
Congratulations for the ICRS 2013 Post Award on INSTRUCT
CellCoTec are pleased to announce their attendance and participation at the 11th ICRS World Congress meeting later this month
CellCoTec is granted the CE mark for its novel, single surgery cartilage repair device
CellCoTec have just completed a Clinical Study Investigator meeting in Warsaw
CellCoTec has successfully completed enrolment of all 40 patients in the first human clinical trial evaluating safety and performance of its unique, patented INSTRUCT cartilage repair therapy.
CellCoTec is delighted to announce the appointment of Fergus MacLeod to the position of Sales and Marketing Director.
CellCoTec is delighted to announce the granting of three new patents which substantially strengthen the company's intellectual property portfolio, for the use of cellular interaction to treat articular carilage lesions of the knee.
CellCoTec, the regenerative medicine company specialising in autologous knee cartilage repair, is pleased to announce the successful completion of the implantation phase of its pilot clinical trial.
Orthopaedic company, CellCoTec has developed and manufactured a complete set of CE marked instrumentation to support the application of the company innovative INSTRUCT cartilage repair therapy
CellCoTec launches a pilot clinical trial by sucessfully implanting its first patient with the INSTRUCT device
CellCoTec has recently completed a successful, independent human cadaver trial